Tag: celgene

July 2, 2019

5 Top Biotechnology ETFs

For investors looking for less volatility compared to stocks, here's an overview of the five largest biotechnology ETFs for consideration.
June 25, 2019

AbbVie to Acquire Allergan in Blockbuster US$63 Billion Deal

According to Tuesday's release, the cash and stock acquisition is expected to be completed sometime in the early part of...
May 28, 2019

8 Small Biotech ETFs

Want to invest in small biotech ETFs? Here we profile eight that life science investors may want to look into.
April 16, 2019

Biotech Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a biotech market update on the biggest news and trends...
April 5, 2019

Celgene and Acceleration Pharma Announce Submission of Luspatercept Biologics License Application to FDA

Celgene (NASDAQ:CELG) and Acceleron Pharma (NASDAQ:XLRN) have announced that Celegene has submitted a biologics license application for luspatercept, which is...
February 28, 2019

An Investor’s Guide to Multiple Sclerosis

March was dubbed Multiple Scleorsis Awareness Month in 2015 by New Jersey Governor Chris Christie. Here's what investors should know.
January 17, 2019

How Will the FDA Shutdown Affect the Biotech Industry?

No information has been released on how the FDA will manage the possible influx of drug applications once the shutdown...